TeselaGen Biotechnology, founded by JBEI’s Nathan Hillson and two partners, says it will significantly reduce the time and cost involved with DNA synthesis and cloning, a multibillion-dollar market. It is based on the j5 software package, which has attracted users from more than 250 institutions worldwide since JBEI made it available last year.